EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Cost-effectiveness of e-cigarettes for smoking cessation at homeless support centres: SCeTCH cRCT

Jinshuo Li iD, Qi Wu iD, Steve Parrott iD, Sharon Cox iD, Francesca Pesola iD, Kirstie Soar iD, Rachel Brown iD, Allison Ford iD, Peter Hajek iD, Caitlin Notley iD, Deborah Robson iD, Emma Ward iD und 10 weitere

Public Health Research · 2025

DOI: 10.3310/gjld2428 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Public Health Research, 2025. Verfasst von Jinshuo Li und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of York, York, UK. Hauptthemen laut MEDLINE: Smoking Cessation, Electronic Nicotine Delivery Systems, Ill-Housed Persons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Public Health Research programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While smoking is common among those experiencing homelessness, the effectiveness of an e-cigarette intervention to reduce smoking in this population is unclear.

Objective

To determine the cost-effectiveness of providing an e-cigarette for smoking cessation in homeless support centres compared to usual care. Design and methods A multicentre two-arm cluster randomised controlled trial, with data collection time points at baseline, 4, 12 and 24 weeks post baseline. Setting and participants Adults (aged 18+) who smoked daily and accessed 32 homeless support centres across six areas of Great Britain received either e-cigarette intervention ( n = 239 in 16 centres) or usual care ( n = 236 in 16 centres) by centre (cluster) randomisation.

Intervention

The intervention was the provision of an e-cigarette starter kit plus 4 weeks’ supply of e-liquids. The usual care comprised very brief advice for smoking cessation and signposting to local Stop Smoking Services. Main outcome measures The total costs included costs of intervention/usual care, costs of smoking cessation outside of the trial and costs of general healthcare services use over 24 weeks. Quality-adjusted life-years were derived from EuroQol-5 Dimensions, five-level version administered at each data collection point. An incremental cost-effectiveness ratio was calculated for 24 weeks using the difference between groups in total costs and quality-adjusted life-years, with cost-effectiveness acceptability curve constructed based on bootstrap to examine uncertainty. A long-term model was employed to project a lifetime incremental cost-effectiveness ratio with probabilistic sensitivity analysis to examine uncertainty. Data sources The analysis over 24 weeks was based on research team records and data collected via self-reported questionnaires. Unit costs for valuation were extracted from published secondary sources. The parameters of the long-term model were based on the 24-week results and published secondary sources.

Results

Mean intervention costs were estimated at £92 [standard error (SE) £0] per participant and mean usual care costs at £50 (SE £0) per participant. Mean total costs per participant were estimated at £3859 (SE £441) in the e-cigarette group and £2716 (SE £386) in the usual care group. Mean quality-adjusted life-years were estimated at 0.303 (SE 0.008) in the e-cigarette group and 0.295 (SE 0.010) in the usual care group. Adjusting for baseline covariates and respective baseline values, e-cigarette group were £1267 (95% confidence interval £600 to £1938) more costly and yielded 0.007 (95% confidence interval −0.017 to 0.027) more quality-adjusted life-years than usual care. The incremental cost-effectiveness ratio was calculated at £181,000 per quality-adjusted life-year gain, with probability of intervention being cost-effective between the incremental cost-effectiveness ratio thresholds of £20,000–30,000 per quality-adjusted life-year gain at 0.9–3.5%. The lifetime model projected the incremental cost-effectiveness ratio at £38,360 per quality-adjusted life-year gained, with the probability of intervention being cost-effective between £20,000 and £30,000 from 47.6% to 49.6%.

Limitations

The imbalance in missing data led to some uncertainty in the results, and healthcare costs recorded in the trial may not reflect the health needs of this population.

Conclusions

Providing e-cigarettes for smoking cessation in homeless support centres was more costly than usual care, but the small increase in quality-adjusted life-years was not significant. Future work Future work should aim to maximise quit rates while being cost-effective and therefore implementable. Funding This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Public Health Research programme as award number NIHR132158.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smoking CessationElectronic Nicotine Delivery SystemsIll-Housed PersonsHumansCost-Benefit AnalysisCost-Effectiveness AnalysisUnited KingdomFemaleMaleAdultQuality-Adjusted Life YearsMiddle Aged

Stichwörter der Autor:innen

COST-EFFECTIVENESS ANALYSISE-CIGARETTESHOMELESSNESSSMOKING CESSATION

Autor:innen und Institutionen

  • Department of Health Sciences, University of York, York, UK.
  • Department of Behavioural Science and Health, University College London, London, UK.
  • Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
  • School of Applied Sciences, London South Bank University, London, UK.
  • Centre for Development, Evaluation, Complexity and Implementation in Public Health Improvement (DECIPHer), School of Social Sciences, Cardiff University, Cardiff, UK.
  • Institute for Social Marketing, University of Stirling, Stirling, UK.

ORCID-Profile: Jinshuo Li, Qi Wu, Steve Parrott, Sharon Cox, Francesca Pesola, Kirstie Soar, Rachel Brown, Allison Ford, Peter Hajek, Caitlin Notley, Deborah Robson, Emma Ward, Anna Varley, Charlotte Mair, Lauren McMillan, Jessica Lennon, Janine Brierley, Amy Edwards, Bethany Gardner, Allan Tyler, Linda Bauld, Lynne Dawkins

Förderung

  • Public Health Research programme

Zitieren

APA

Li, J., Wu, Q., Parrott, S., Cox, S., Pesola, F., Soar, K., Brown, R., Ford, A., Hajek, P., Notley, C., Robson, D., Ward, E., Varley, A., Mair, C., McMillan, L., Lennon, J., Brierley, J., Edwards, A., Gardner, B., …, & Dawkins, L. (2025). Cost-effectiveness of e-cigarettes for smoking cessation at homeless support centres: SCeTCH cRCT. Public Health Research. https://doi.org/10.3310/gjld2428

Vancouver

Li J, Wu Q, Parrott S, Cox S, Pesola F, Soar K, et al. Cost-effectiveness of e-cigarettes for smoking cessation at homeless support centres: SCeTCH cRCT. Public Health Research. 2025. doi:10.3310/gjld2428

BibTeX
@article{Li2025,
  author = {Li, Jinshuo and Wu, Qi and Parrott, Steve and Cox, Sharon and Pesola, Francesca and Soar, Kirstie and Brown, Rachel and Ford, Allison and Hajek, Peter and Notley, Caitlin and Robson, Deborah and Ward, Emma and Varley, Anna and Mair, Charlotte and McMillan, Lauren and Lennon, Jessica and Brierley, Janine and Edwards, Amy and Gardner, Bethany and Tyler, Allan and Bauld, Linda and Dawkins, Lynne},
  title = {Cost-effectiveness of e-cigarettes for smoking cessation at homeless support centres: SCeTCH cRCT},
  journal = {Public Health Research},
  year = {2025},
  doi = {10.3310/gjld2428}
}
Kostenlos starten →